Skip to main content

Table 4 Fever treatment by malaria test result across all private outlets

From: Private sector role, readiness and performance for malaria case management in Uganda, 2015

 

Malaria test positive

% (95% CI)

N = 266

Malaria test negative

% (95% CI)

N = 250

Not tested

% (95% CI)

N = 753

Any anti-malarial

83.0 (74.6–89.0)

14.3 (9.3–21.2)

50.8 (44.4–57.3)

Any ACT

60.0 (53.3–66.3)

10.2 (6.5–15.5)

42.7 (36.4–49.3)

QA ACT

48.5 (41.3–55.7)

6.6 (3.7–11.6)

33.9 (27.7–40.7)

Non-quality assured ACT

12.2 (8.1–18.1)

3.5 (1.3–9.4)

8.9 (5.6–13.7)

Non-artemisinin therapya

14.4 (9.6–21.1)

3.6 (1.3–9.3)

8.4 (5.9–11.8)

Artemisinin monotherapyb

14.9 (9.3–23.0)

0.5 (0.1–3.6)

1.1 (0.4–3.3)

Antibiotic

42.5 (34.1–51.3)

54.7 (45.7–63.4)

24.1 (18.9–30.1)

Antipyretic

78.7 (71.4–84.5)

61.2 (50.6–70.9)

64.9 (59.5–70.0)

Patient received a prescription for an anti-malarial, but did not receive an anti-malarial at the outlet (exiting without treatment)

0.2 (0.1, 0.8)

3.3 (0.7, 14.4)

0.2 (<0.1, 1.8)

  1. aPrimarily quinine injections, tablets, syrups as well as SP tablets and a few chloroquine tablet anti-malarials
  2. bPrimarily artemether injections